Objectives. Our primary objective was to develop and evaluate an intervention to increase recruitment in a multicenter pediatric randomized clinical trial (RCT). Our secondary objective was to assess the impact beyond 120 days. Methods. The study was conducted at 17 academic centers participating in a pediatric RCT. The intervention consisted of utilizing a recruitment assessment tool at a site visit or teleconference with key site personnel. Results. We found a significant increase in the number of individuals enrolled for all 17 sites at 120 days postintervention (mean = 1.12 per site; median = 1 per site; 95% confidence interval = 1-2; P = .04). No significant differences were apparent beyond the first 120 days postintervention. Conclusions. Successful recruitment in RCTs is essential to the quality, generalizability, and cost-effectiveness of clinical research. Implementation of this recruitment intervention may effectively increase recruitment in RCTs. Beyond the first 120 days postintervention, repeated interventions may be required. What is new? Despite general and pediatric-specific challenges to recruitment in RCTs, a paucity of evidence exists on effective recruitment strategies or assessment tools to reliably enhance recruitment. We developed a recruitment intervention for use in RCTs that enables clinical researchers to enhance recruitment.
Introduction
Successful recruitment of participants in randomized clinical trials (RCTs) is essential for evaluating the effectiveness and safety of health care interventions. 1 Yet the proportion of trials that either fail to achieve recruitment targets or require an extended recruitment period ranges from 50% to 63%. 1, 2 Underrecruitment results in inadequate sample size, reduced statistical power, type II error, poor generalizability, and demoralized staff. 3, 4 Extension of recruitment periods results in increased cost, delays in implementation of effective interventions, risk of study closure, and risk of opting for a less robust study design. 3, 5 In pediatric trials involving pediatric participants, parents report giving consent for their child as more difficult than giving consent for themselves. 5 Additional challenges specific to pediatrics include the parents' (1) sense of responsibility, (2) fear of regretting their decision, (3) need to protect their child that outweighs their sense of altruism, (4) perception of uncertainty versus hope, and (5) relationship with their pediatrician. 5 Good relationships and communication between parents and clinical researchers offer parents a sense of safety and trust, which in turn influences their decision to participate in a clinical trial. 5 Despite these general and pediatric-specific challenges to recruitment in RCTs, a paucity of evidence exists regarding effective recruitment strategies. 2, 3, 6 There are no previously standardized recruitment interventions or guidelines on site visits or conference calls in RCTs. Our primary objective was to develop and evaluate an intervention, consisting of a recruitment assessment tool and a site visit or teleconference with key site personnel and a recruitment specialist, to review recruitment processes and identify problem areas and strategies to increase recruitment. Our secondary objective was to assess the sustainability of this intervention beyond 120 days.
Methods

Development of the Intervention
We searched PubMed (4/2009) using the search term recruitment strategy; 493 articles were identified, of which 21 were clinically relevant: (1) randomized or quasi-randomized study design, (2) health care-related studies, and (3) inclusion of methods to increase recruitment directed at research ethics committees, collaborators, or participants. The study team at Children's Hospital of Pittsburgh (CHP), in collaboration with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) core principal investigators (PIs), developed the recruitment assessment tool that included reported strategies together with those previously used at CHP to enroll children with common pediatric problems in large RCTs (see Table 1 ). The items in the recruitment assessment tool served as a template to gather qualitative data, allowing for open-ended responses and quantitative data, such as the specific number of patients screened, eligible, and enrolled from each referral pathway; items were not rated on a scale. The intervention consisted of the recruitment assessment tool and a site visit or teleconference with key site personnel and a recruitment specialist to review current recruitment processes and identify problem areas and strategies to increase recruitment. The blank assessment tool was provided to sites in advance of the visit or teleconference, so that the sites could prepare for the upcoming intervention. The assessment tool was then completed and reviewed at the time of the site visit or teleconference by the recruitment specialist (SB) with key site personnel (PI, study coordinator). The intervention did not meet the federal definition of human subjects research, and therefore, the University of Pittsburgh Institutional Review Board did not require formal review.
Of the 18 academic centers actively recruiting in the NIDDK-RIVUR study-a randomized, placebo-controlled, double-blind clinical trial-17 were included in the intervention during a site visit (11 centers) or via teleconference (6 centers) based on feasibility for each site ( Table 2 ). One actively recruiting academic center was excluded-namely, CHP-because this site's experiences were incorporated into the development of the assessment tool. Both site visits and teleconferences required that the recruitment specialist (SB) and key site personnel (PI, study coordinator) convene to (1) review and complete the recruitment assessment tool, (2) tour relevant referral sources (site visits only), (3) debrief the PI and study coordinator; and (4) provide in-depth sitespecific analysis of current recruitment strategies and recommendations to optimize recruitment distributed to the PI and study coordinator, core site PIs, NIDDK Project Officer, and the PI of the data coordinating center. Steps 1 to 3 of the intervention took approximately 6 hours to complete for the site visits and 5 hours to complete for the teleconferences.
Step 4 took approximately 6 hours to complete.
Statistical Analyses
Data for the 17 participating academic centers (11 site visits and 6 teleconferences) were analyzed ( Table 2 ). The Wilcoxon signed-rank test was used to determine if differences in number of participants enrolled 120 days preintervention to (1) 120 days postintervention and (2) 121 to 240 days postintervention were equal to 0. The null hypothesis that the difference is 0 was tested against a 2-sided alternative.
Results
The differences between the number of participants enrolled 120 days preintervention and postintervention and 120 days preintervention and 121 to 240 days postintervention for all 17 sites were computed ( Table 2) . A significant increase in the number of participants enrolled for all 17 sites at 120 days postintervention (mean = 1.12 per site; median = 1 per site; 95% confidence interval [CI] = 1-2; P = .04) was found. No significant differences were apparent in the number of participants enrolled for all 17 sites 121 to 240 days postintervention (mean = 0 per site; median = 0 per site; 95% CI = −1 to 1; P = .96) and beyond. A summary of the most frequent and useful recruitment recommendations are summarized in Table 3 . A range of 4 to 15 of these recommendations from Table 3 were implemented at each site. The most useful aspects of this intervention reported by sites included (1) utilizing the assessment tool to re-evaluate the screening and enrollment processes in a frank manner with outside oversight and (2) the subsequent internal effort to establish specific action items in response to debriefing, site-specific analysis, and recommendations provided by the recruitment specialist. Sites further reported that acknowledgement of their successful recruitment pathways and the overall intervention process was encouraging and motivating. No significant qualitative differences were found in terms of geography, size of institution, nor level of participation. 
Discussion
Our recruitment intervention for a pediatric RCT enabled clinical researchers' assessment and optimization of enrollment of children in this clinical trial. When implemented at 17 academic centers participating in the NIDDK-RIVUR study, the number of participants recruited at 120 days postintervention increased. Outcomes were prespecified and tested in a "real trial" scenario. Although the gain of approximately 1 participant per site in the first 120-day period is modest, if sustained, it would equate to 3 participants per site per year, which represented 10.5% of the enrollment target. The immediate postintervention improvement demonstrates that early intervention is critical to maximize recruitment. Beyond 120 days postintervention, no significant differences were apparent in the number of participants enrolled; to sustain the increase in recruitment beyond 120 days, repeated interventions may be required.
Limitations of our study include that (1) it was not designed as a randomized trial, and investigators were fully aware of the intervention; (2) although this multicenter trial had resources for a recruitment specialist to conduct site visits, a teleconference using the tool is more cost-effective; (3) bias might have resulted in the decision to deliver the intervention via site visit or teleconference; and (4) it is unclear whether the intervention actually led to the increase in recruitment versus the "Hawthorne effect," in which behavioral studies have found a change in performance in response to just being observed.
It was not possible to compare the subset of site visits to teleconferences to determine the more effective method for delivering this intervention because of insufficient statistical power.
A recent Cochrane review analyzing strategies to improve recruitment in RCTs identified 24 studies involving interventions aimed directly at trial participants, whereas only 3 interventions aimed at increasing recruitment of participants. 1 Limitations outlined in the review included trials being hypothetical, small, and underpowered and introducing many potential biases. 1 Previously reported clinician barriers to participation in RCTs include (1) time constraints, (2) lack of staff and training, (3) loss of professional autonomy, (4) concern for patients, (5) difficulty with consent, and (6) lack of rewards and recognition. 2 Previously reported barriers to participation include (1) additional procedures, appointments, travel, and cost; (2) preference for a particular treatment; (3) concern of uncertainty of treatment; and (4) concern about biased information. 2 The site-specific recommendations provided by the recruitment specialist were directly based on information gathered from the recruitment assessment tool and reported strategies, together with those previously used at CHP to enroll children with common pediatric problems in large RCTs. Developing a trusting relationship between the researcher and referring clinician 7 was particularly important and one of the most cost-effective methods. 8 Clinicians who considered the researcher to be honest and having the best interest for his/her patients and who believed that the research was valuable were more likely to refer patients.
Our results were consistent with previously reported effective strategies: (1) office visits 9 ; (2) fostering a positive attitude toward research 10 ; (3) stimulating intellectual curiosity in the research question 11 ; (4) minimizing workload, 12 such as creating a 1-step process for clinicians to refer potentially eligible patients; (5) emphasizing trial safety and relevance 9,10,12 ; (6) educating clinicians on research and potential benefits to study participants 10, 11 ; and (7) providing direct access to the trial's PI to foster consultation and line of communication between the clinician and researcher. 9, 13 The recruitment specialist specifically advocated that the PI and study coordinator visit "high-yield" practices to build trusting relationships, review recent clinical care recommendations and relevant recent publications, and discuss the RCT. The study team at CHP provided clinicians with clinical trial update letters, brochures, and business cards. The study team at CHP met with practice managers (usually the gatekeeper for clinicians) and as many office staff, nurses, and medical assistants as possible to gain buy-in from a wide range of providers. This trusting relationship established between the primary care clinicians and the research team resulted in parents of potentially eligible children initially learning about the RCT through a discussion with their trusted clinician.
Strategies the study team at CHP found effective when communicating with families of eligible children included the following: (1) incorporating culturally specific interventions, 3, 14 such as a Spanish-speaking researcher and consent involving the patient's father with Hispanic children and grandmother, if available, with African American children; (2) creating study-specific comprehensive Web sites and brochures; (3) contacting families as soon as possible after the initial diagnosis or procedure, given the acute relevance of the concern; (4) placing a follow-up phone call within 1 to 2 days of the initial RCT discussion; (5) offering assistance in scheduling diagnostic or imaging tests through a "concierge service"; (6) encouraging questions and open discussions; and (7) providing 24/7 access to the PI.
Recruitment strategies previously reported as not being cost-effective included media publicity in newspapers, 6 pre-enrollment personalized letters, and postcards. 3, 14 Financial incentives for clinicians negatively affect recruitment and result in conflicts of interest, coercion of patients, and decreased quality of research. 2, 11 Similarly, altering study design to patient-preferred treatment rather than randomization and surveillance rather than placebo were reported to be ineffective in enhancing recruitment. 2, 3 We conclude that implementation of our recruitment assessment tool with site-specific interventions effectively increased recruitment in an RCT in the immediate 120-day postintervention period. Further research is required to determine the more effective method of delivery of the intervention: site visit or teleconference. Widespread, early, and periodic use of such an assessment tool in other trials may result-if enhanced recruitment is further documented-in more cost-effective use of health care research resources and in a more fulfilling research experience for clinicians and participants.
